ArticleJournal of experimental & clinical cancer research : CR2019

Mortaparib, a novel dual inhibitor of mortalin and PARP1, is a potential drug candidate for ovarian and cervical cancers.

Jayarani F Putri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.